Related Experiment Video
Updated: Jun 19, 2026

Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity
Published on: February 9, 2024
Mitochondrial MDM4 (MDMX): an unpredicted role in the p53-mediated intrinsic apoptotic pathway
Francesca Mancini1, Fabiola Moretti
1Institute of Neurobiology and Molecular Medicine, National Council of Research/Fondazione Santa Lucia, Roma, Italy.
Abstract:
p53 is a crucial regulator of cell response to DNA damage. MDM4 and MDM2 are the two main negative regulators of p53 activity. Upon DNA damage, their constraint is released and p53 becomes activated and exerts its safeguard function by arresting cell growth or by killing excessively damaged cells. Under these conditions, increasing data suggest that MDM4 and MDM2 play novel roles. In this respect, we recently published that MDM4 exerts a positive activity towards p53 mitochondrial apoptosis. We observed that a fraction of MDM4 stably localizes at the mitochondria where upon lethal stress conditions, promotes the mitochondrial localization of p53 phosphorylated at Ser46 (p53Ser46(P)) and facilitates its binding to BCL2, cytochrome C release and apoptosis. Most importantly, we observed a correlation of MDM4 expression with cisplatin-resistance in a group of human ovarian cancers suggesting that MDM4 proapoptotic activity may have in vivo relevance. Here, we discuss about these and some new findings and compare them with previous data trying to settle some apparent contradictions. In addition, this review discusses the potential relevance of our data to the field of human cancer.
Insights
MDM4 promotes p53-mediated apoptosis at mitochondria upon DNA damage. This proapoptotic function may contribute to cisplatin resistance in ovarian cancers, highlighting MDM4
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- p53 is a key regulator of cellular response to DNA damage.
- MDM4 and MDM2 are primary negative regulators of p53 activity.
- Upon DNA damage, p53 activation leads to cell cycle arrest or apoptosis.
Purpose of the Study:
- To investigate novel roles of MDM4 and MDM2 in p53 regulation.
- To explore MDM4's positive role in p53-mediated mitochondrial apoptosis.
- To assess the in vivo relevance of MDM4's proapoptotic activity in human cancers.
Main Methods:
- Mitochondrial localization studies of MDM4.
- Analysis of p53 phosphorylation at Ser46 (p53Ser46(P)).
- Assessment of BCL2 binding, cytochrome C release, and apoptosis.
- Correlation analysis of MDM4 expression with cisplatin resistance in ovarian cancer.
Main Results:
- MDM4 localizes to mitochondria and promotes p53Ser46(P) mitochondrial import.
- MDM4 facilitates p53 binding to BCL2, leading to cytochrome C release and apoptosis.
- MDM4 expression correlates with cisplatin resistance in human ovarian cancers.
Conclusions:
- MDM4 plays a proapoptotic role by enhancing p53 activity at the mitochondria.
- MDM4's mitochondrial function has potential implications for cancer treatment resistance.
- Further research into MDM4's role in cancer is warranted.
More Related Videos
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
13:20Detection of Mitochondria Membrane Potential to Study CLIC4 Knockdown-induced HN4 Cell Apoptosis In Vitro
Published on: July 17, 2018
Related Concept Videos
Abnormal Proliferation
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
Apoptosis
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle